Swedish (OMX) Wachstum Aktien Pharmaceuticals & Biotech

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

AKTUALISIERT Aug 17, 2026

Entdecken Sie Swedish Pharmaceuticals & Biotech Wachstumsaktien die sich auf der OMX. Nach prognostiziertem Wachstum sortiert, verzeichnen diese Pharmaceuticals & Biotech Stocks im Vergleich zu anderen Unternehmen ein höher als erwartetes Gewinn- oder Umsatzwachstum.

89 Unternehmen

Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite
IRLAB A	SEK 1.68	11.0%	-45.0%	SEK 249.2m	SEK 7.50	2.7	130.2%	n/a
ACE	SEK 0.60	5.3%	-87.5%	SEK 80.1m	SEK 2.40	1.0	109.3%	n/a
MOB	SEK 11.78	14.6%	42.8%	SEK 555.8m	SEK 16.00	33.2	108.6%	n/a
VITR	SEK 88.40	-0.7%	-34.4%	SEK 12.0b	SEK 129.60	3.5	103.8%	1.2%
ACTI	SEK 5.10	-5.6%	-71.2%	SEK 134.4m	SEK 25.00	2.8	98.9%	n/a
BICO	SEK 16.28	1.8%	-53.4%	SEK 1.1b	SEK 23.50	0.7	96.0%	n/a
ALZCUR	SEK 6.74	0.3%	49.1%	SEK 929.4m	SEK 14.30	82.8	75.8%	n/a
DVYSR	SEK 60.20	-5.3%	-58.8%	SEK 1.0b	SEK 97.58	67.8	71.3%	n/a
ONCO	SEK 1.71	7.6%	-69.4%	SEK 676.3m	SEK 2.50	8.1	67.9%	n/a
SYNACT	SEK 19.78	5.1%	6.5%	SEK 1.1b	SEK 35.00	5.7	65.3%	n/a
PILA	SEK 1.30	-3.0%	-47.4%	SEK 59.2m	SEK 2.50	52.5	63.8%	n/a
ISOFOL	SEK 0.85	0.4%	-3.0%	SEK 272.1m	SEK 3.60	2.9	62.5%	n/a
BIOA B	SEK 323.00	0.9%	37.8%	SEK 28.7b	SEK 316.75	134.4	62.3%	0.6%
DMYD B	SEK 1.01	-1.2%	-90.9%	SEK 156.8m	SEK 1.40	363.1	58.2%	n/a
ELIC	SEK 2.75	10.0%	-52.7%	SEK 183.2m	SEK 7.60	17.2	49.0%	n/a
EGTX	SEK 7.09	1.4%	27.3%	SEK 3.3b	SEK 15.33	52.2	46.8%	n/a
ONCOZ	SEK 5.90	2.6%	-9.6%	SEK 82.9m	SEK 11.50	1167.4	46.2%	n/a
SECARE	SEK 21.50	0.2%	-40.5%	SEK 3.4b	SEK 39.50	42.9	45.6%	1.3%
BINV	SEK 24.55	6.0%	-33.6%	SEK 1.6b	SEK 95.00	7.4	43.8%	n/a
GENO	SEK 19.88	0.9%	-16.1%	SEK 1.3b	SEK 33.00	65.4	40.7%	n/a
HNSA	SEK 41.90	5.8%	40.7%	SEK 4.3b	SEK 73.00	22.5	40.4%	n/a
CAMX	SEK 615.00	1.0%	-8.1%	SEK 36.6b	SEK 793.00	54.0	35.9%	n/a
INIT	SEK 2.34	-10.0%	-30.8%	SEK 160.2m	SEK 8.03	6.0	35.5%	n/a
BIOVIC B	SEK 0.52	-5.1%	-19.2%	SEK 152.4m	n/a	11.3	33.6%	n/a

Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite
IRLAB A	SEK 1.68	11.0%	-45.0%	SEK 249.2m	SEK 7.50	2.7	130.2%	n/a
ACE	SEK 0.60	5.3%	-87.5%	SEK 80.1m	SEK 2.40	1.0	109.3%	n/a
MOB	SEK 11.78	14.6%	42.8%	SEK 555.8m	SEK 16.00	33.2	108.6%	n/a
VITR	SEK 88.40	-0.7%	-34.4%	SEK 12.0b	SEK 129.60	3.5	103.8%	1.2%
ACTI	SEK 5.10	-5.6%	-71.2%	SEK 134.4m	SEK 25.00	2.8	98.9%	n/a
BICO	SEK 16.28	1.8%	-53.4%	SEK 1.1b	SEK 23.50	0.7	96.0%	n/a
ALZCUR	SEK 6.74	0.3%	49.1%	SEK 929.4m	SEK 14.30	82.8	75.8%	n/a
DVYSR	SEK 60.20	-5.3%	-58.8%	SEK 1.0b	SEK 97.58	67.8	71.3%	n/a
ONCO	SEK 1.71	7.6%	-69.4%	SEK 676.3m	SEK 2.50	8.1	67.9%	n/a
SYNACT	SEK 19.78	5.1%	6.5%	SEK 1.1b	SEK 35.00	5.7	65.3%	n/a
PILA	SEK 1.30	-3.0%	-47.4%	SEK 59.2m	SEK 2.50	52.5	63.8%	n/a
ISOFOL	SEK 0.85	0.4%	-3.0%	SEK 272.1m	SEK 3.60	2.9	62.5%	n/a
BIOA B	SEK 323.00	0.9%	37.8%	SEK 28.7b	SEK 316.75	134.4	62.3%	0.6%
DMYD B	SEK 1.01	-1.2%	-90.9%	SEK 156.8m	SEK 1.40	363.1	58.2%	n/a
ELIC	SEK 2.75	10.0%	-52.7%	SEK 183.2m	SEK 7.60	17.2	49.0%	n/a
EGTX	SEK 7.09	1.4%	27.3%	SEK 3.3b	SEK 15.33	52.2	46.8%	n/a
ONCOZ	SEK 5.90	2.6%	-9.6%	SEK 82.9m	SEK 11.50	1167.4	46.2%	n/a
SECARE	SEK 21.50	0.2%	-40.5%	SEK 3.4b	SEK 39.50	42.9	45.6%	1.3%
BINV	SEK 24.55	6.0%	-33.6%	SEK 1.6b	SEK 95.00	7.4	43.8%	n/a
GENO	SEK 19.88	0.9%	-16.1%	SEK 1.3b	SEK 33.00	65.4	40.7%	n/a
HNSA	SEK 41.90	5.8%	40.7%	SEK 4.3b	SEK 73.00	22.5	40.4%	n/a
CAMX	SEK 615.00	1.0%	-8.1%	SEK 36.6b	SEK 793.00	54.0	35.9%	n/a
INIT	SEK 2.34	-10.0%	-30.8%	SEK 160.2m	SEK 8.03	6.0	35.5%	n/a
BIOVIC B	SEK 0.52	-5.1%	-19.2%	SEK 152.4m	n/a	11.3	33.6%	n/a